Edmond de Rothschild Equity Strategies IV (ERES IV), advised by Elyan Partners, has completed the acquisition of a majority stake in CRO Oncodesign Services first announced earlier in the year….
Edmond de Rothschild Equity Strategies IV (ERES IV), advised by Elyan Partners, has completed the acquisition of a majority stake in CRO Oncodesign Services first announced earlier in the year….
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


